businesspress24.com - Anatomy of a Drug Manufacturing Plant (Last in a Three-Part Series Examining the Financial Impact of
 

Anatomy of a Drug Manufacturing Plant (Last in a Three-Part Series Examining the Financial Impact of New Plant Construction), an Industrial Info News Alert

ID: 1125021

(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 06/18/12 -- Reported by Annette Kreuger for Industrial Information Resources Sugar Land, Texas) -- Once construction has wrapped up and the validation process for a new pharmaceutical or biotech () plant is complete, it is time to begin production. Not only does an operational plant manufacture drug products that improve the public's physical health, but it also sets off a ripple effect that is beneficial to the financial well being of the host community, county and state.

In the past 12-month period (6/2011-6/2012), 83 new Pharmaceutical & Biotech Industry plants began operations in North America. Industrial Info is tracking 185 additional new-build (or lease and equip) projects in various stages of planning, engineering or construction.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.





Contact:
Joe Govreau
713-783-5147




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  GENEWIZ, Inc. Announces CLIA Certification
Trimel Hosts Tefina(TM) Investigator Meeting
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 18.06.2012 - 04:10 Uhr
Sprache: Deutsch
News-ID 1125021
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SUGAR LAND, TX


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 165 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Anatomy of a Drug Manufacturing Plant (Last in a Three-Part Series Examining the Financial Impact of New Plant Construction), an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von

Industrial Info Resources (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Industrial Info Resources



 

Who is online

All members: 10 568
Register today: 1
Register yesterday: 2
Members online: 0
Guests online: 99


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.